SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin
Keywords:
Área de Medicina Clínica y Epidemiología
Osteosarcoma
Pharmacogenetics
Doxorubicin
L-type amino acid transporter 2
Early disease progression
Note:
This is an
open-access article distributed under the
terms of the Creative Commons Attribution
License (CC BY). The use, distribution or
reproduction in other forums is permitted,
provided the original author(s) and the
copyright owner(s) are credited and that the
original publication in this journal is cited, in
accordance with accepted academic practice.
No use, distribution or reproduction is
permitted which does not comply with these
terms.
Citation:
Hurkmans, E. G. E.; Koenderink, J. B.; an den Heuvel, J. J. M. W.; et al. "SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin". Frontiers In Pharmacology. 13, 2022, 1042989
Statistics and impact
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.